Accuracy Analysis of Deep Learning Methods in Breast Cancer Classification: A Structured Review

Analysis

Why This Paper Matters

Breast cancer diagnosis via histopathological imaging is time-consuming and complex, yet crucial for early intervention. Deep learning has emerged as a powerful tool, but achieving high accuracy while avoiding overfitting remains a challenge. This structured review is significant because it consolidates the state of the art in DL-based classification of histopathological breast cancer images, offering a clear picture of current methods and their performance. By systematically analyzing literature from Scopus and Web of Science up to November 2022, the paper provides a valuable resource for researchers and practitioners seeking to understand the landscape and identify gaps.

The paper also highlights practical issues like imbalanced data and incorrect labeling, which are often overlooked in technical papers but are critical for real-world deployment. By discussing mitigation strategies such as pre-processing, ensemble methods, and normalization, it bridges the gap between theoretical models and clinical application. This makes the review not just an academic exercise but a practical guide for developing robust diagnostic tools.

Technical Contributions

The paper's main contribution is its systematic review methodology, which filters and analyzes a large body of research to extract key trends. It categorizes DL approaches, with a focus on convolutional neural networks (CNNs) and hybrid models, which are identified as the most cutting-edge. The review also outlines common challenges and solutions:

• Overfitting: Addressed through regularization, data augmentation, and ensemble methods.
• Imbalanced data: Handled via resampling, synthetic data generation, and cost-sensitive learning.
• Incorrect labeling: Mitigated by robust training techniques and noise-robust loss functions.
• Pre-processing and normalization: Enhance image characteristics to improve model performance.

The paper emphasizes the need for hybrid approaches that combine CNNs with other architectures or techniques to push accuracy further. It also suggests that future research should focus on developing more sophisticated variants to reduce overfitting while maintaining high precision.

Results

While the abstract does not provide specific quantitative metrics, the review's findings indicate that DL methods, particularly CNNs and hybrids, achieve state-of-the-art performance in breast cancer classification. The paper synthesizes results from multiple studies, showing consistent improvements over traditional methods. However, it also notes that performance varies depending on dataset, preprocessing, and model architecture, underscoring the need for standardized benchmarks.

Significance

This review has significant implications for the AI and medical imaging communities. By providing a structured analysis of existing DL approaches, it helps researchers avoid redundant work and focus on novel innovations. The identification of CNNs and hybrids as leading methods suggests that future breakthroughs may come from further hybridization or integration with other AI techniques. For clinicians, the review underscores the potential of DL to assist in early diagnosis, potentially reducing mortality rates. The paper also highlights the importance of addressing data challenges, which is crucial for translating research into clinical practice. Overall, it serves as a foundational reference for advancing automated breast cancer diagnosis.